Air cargo group Pharma.Aero has launched a new project to identify the attributes required for an environmentally friendly transport of pharma products.
The primary goal of the project is to assist pharmaceutical manufacturers and freight forwarders in integrating sustainability considerations into their freight procurement and lane assessment processes to help reduce their Scope 3 (emissions created by suppliers) reduction targets.
The findings of the Green Air Pharma Logistics Project will be presented in a technical report shared exclusively with Pharma.Aero members and partners.
However, key takeaways will also be part of a white paper accessible to the broader industry.
The project is being led by Jaisey Yip, vice president cargo business division at Changi Airport Group, which is a strategic member of Pharma.Aero.
"Climate change is a global health issue. The Pharma and Life Science industry is regarded as a carbon-intensive sector, and Scope 3 emissions account for over 80% of total emissions generated," said Yip.
"Sustainability is an important focus area for Changi Airport Group. As airports serve as a common platform for various aviation partners, we believe in actively identifying industry challenges and measures toward building a sustainable air cargo hub."
The project has already produced an interim report following interviews with stakeholders.
Frank Van Gelder, secretary general of Pharma.Aero, said: "It is crystal clear that addressing sustainability challenges correctly is only possible through cross-industry collaborative initiatives.
"We embarked on this project fully aware that it may take a few more years to achieve our envisioned goals.
"Our ultimate goal is to pave the way towards a greener future for pharmaceutical logistics."
https://www.aircargonews.net/sectors/pharma-logistics/pharma-aero-and-neutral-air-partner-sign-mou-to-support-life-science-and-medtech-transportation/
https://www.aircargonews.net/sectors/pharma-logistics/pharma-aero-welcomes-new-members/
